VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,534,709 | -14.6% | 3,467,156 | 0.0% | 3.00% | -17.7% |
| Q2 2023 | $55,647,854 | +106.8% | 3,467,156 | 0.0% | 3.64% | +111.8% |
| Q1 2023 | $26,905,131 | -56.3% | 3,467,156 | +9.0% | 1.72% | -52.9% |
| Q4 2022 | $61,560,903 | -9.2% | 3,181,442 | 0.0% | 3.65% | -7.4% |
| Q3 2022 | $67,797,000 | +56.6% | 3,181,442 | 0.0% | 3.94% | +9.4% |
| Q2 2022 | $43,299,000 | -42.1% | 3,181,442 | 0.0% | 3.61% | -36.4% |
| Q1 2022 | $74,732,000 | -4.0% | 3,181,442 | +9.1% | 5.67% | +24.7% |
| Q4 2021 | $77,883,000 | +54.0% | 2,914,776 | 0.0% | 4.55% | +51.9% |
| Q3 2021 | $50,571,000 | +30.8% | 2,914,776 | 0.0% | 3.00% | +34.4% |
| Q2 2021 | $38,650,000 | – | 2,914,776 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |